Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Immunomedics, Inc.
  6. Summary
    IMMU   US4529071080

IMMUNOMEDICS, INC.

(IMMU)
 SummaryChartsNewsRatingsCompany 
Company
Immunomedics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer. Its technologies allow it to create humanized antibodies that can be used either alone in unlabeled or naked form, or conjugated with radioactive isotopes, chemotherapeutics, cytokines or toxins. It has a pipeline of six clinical-stage product... 
More about the company
Ratings of Immunomedics, Inc.
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
-
More Ratings
All news about IMMUNOMEDICS, INC.
04/20Protara Therapeutics Announces Appointment of Martin Sebastian Olivo, M.D. as Chief Med..
AQ
01/11GILEAD SCIENCES : Raises Product Sales Guidance on Remdesivir Demand, Narrows Earnings Out..
DJ
2020GILEAD SCIENCES : Advances Oncology Portfolio with New Data from Phase 3 ASCENT Trial of T..
AQ
2020GILEAD SCIENCES : to Pay $1.4 Billion for Hepatitis Drug Maker MYR GmbH of Germany
DJ
2020GILEAD SCIENCES : Announces Third Quarter 2020 Financial Results
AQ
2020Gilead Quarterly Revenue Rises on Remdesivir Sales -- Update
DJ
2020GILEAD SCIENCES : Quarterly Revenue Rises on Remdesivir Sales
DJ
2020GILEAD SCIENCES : Completes Acquisition of Immunomedics, Inc.
AQ
2020IMMUNOMEDICS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting..
AQ
2020Immunomedics, Inc. Announces Board Changes
CI
2020IMMUNOMEDICS, INC.(NASDAQGM : IMMU) dropped from Russell Midcap Growth Index
CI
2020IMMUNOMEDICS, INC.(NASDAQGM : IMMU) dropped from Russell 3000 Growth Index
CI
2020IMMUNOMEDICS, INC.(NASDAQGM : IMMU) dropped from Russell Small Cap Completeness Index
CI
2020IMMUNOMEDICS, INC.(NASDAQGM : IMMU) dropped from Russell 2500 Growth Index
CI
2020IMMUNOMEDICS, INC.(NASDAQGM : IMMU) dropped from Russell 1000 Growth Index
CI
More news
News in other languages on IMMUNOMEDICS, INC.
02/05La banque d'affaires Lazard a vu bondir son bénéfice net en 2020
2020BB Biotech sombre dans le rouge au 3e trimestre, reste à flot sur 9 mois
2020HBM im Halbjahr 2020/21 mit Gewinnsprung - Zuversichtlich ins zweite Halbjahr
2020Aktien New York Schluss: Übernahmen bescheren starken Wochenauftakt
2020Wall Street profite du rebond de la tech
More news
Chart IMMUNOMEDICS, INC.
Duration : Period :
Immunomedics, Inc. Technical Analysis Chart | IMMU | US4529071080 | MarketScreener
Managers and Directors
Andrew D. Dickinson President, Treasurer & Director
Loretta M. Itri Chief Medical Officer
Brett A. Pletcher Secretary & Director
Christina Carlson Director & Assistant Secretary
Kurt J. W. Andrews Chief Human Resources Officer
Sector and Competitors
1st jan.Capi. (M$)
IMMUNOMEDICS, INC.0.00%20 324
MODERNA, INC.311.74%173 624
LONZA GROUP AG30.56%59 611
IQVIA HOLDINGS INC.46.01%50 128
CELLTRION, INC.-23.54%31 745
SEAGEN INC.-7.88%29 353